Drug Topics - February 2009 - (Page 22) Issues & Trends Fact Niche pharmacies serve special populations Pediatric and geriatric pharmacists becoming more visible. Heide Aungst, Senior Editor 6.8 million children A Network SEE INDEX PAGE 8 Issues & Trends For more info on this topic, see www.drugtopics.com ‘Diabesity’ driving the need for pediatric pharmacies In the age of “diabesity” — a word referring to two epidemics confronting children today: diabetes and obesity – PPAG works to educate pharmacists about the medication needs of children with those diseases. “When you have a kid that looks more like an adult (in terms of the disease process) but still has the physiology of a child, what do you do with that? How do you deal with W W W.D R U GTO P I C S .C O M 22 DRUG TOPICS Februar y 2009 COURTESY GETTY IMAGES / RUBBERBALL PRODUCTIONS / MIKE KEMP my Hannig RPh, doesn’t always get to meet the people whose prescriptions she fills. They run right past her. After all, the wooden train and the stuffed animals are at the back of Kids ’N Cures Pharmacy in Boardman, Ohio. Hannig is one of a handful of pharmacists providing specialized services in pediatric community pharmacies throughout the country. Serving the other end of the demographic market are pharmacists like Becky Culbertson, RPh, of 50-Plus Pharmacy in Kansas City, Mo., which is one of the few pharmacies dedicated to serving seniors. Specialty, or niche community pharmacies, though still few in number, are reaching out to meet the growing needs of two populations with special needs — children and senior citizens. Both types of pharmacies involve a significant amount of compounding to make formulas that meet the needs of the vulnerable populations they serve. Both also have notfor-profit associations working for the professionals in their specialties. But there’s one big difference: You can get certified in geriatric pharmacy, but not in pediatric pharmacy. With a wave of aging baby boomers advancing on the horizon, the American Society of Consultant Pharmacists started the Commission for Certification in Geriatric Pharmacy in 1997. Since then, 1,800 pharmacists have taken the exam and been certified. Many work for nursing homes, which according to legal mandates, must have a pharmacist review patients’ prescriptions every 30 days. To serve pediatric pharmacists, the Memphis-based Pediatric Pharmacy Advocacy Group (PPAG) started in 1978 to serve pharmacists at children’s hospitals, according to its executive director Matthew Helms. Today the group has about 700 members. Helms estimates all but “five or six” work for hospitals. Helms explains that while there are few communitybased pediatric pharmacies nationwide — the group currently doesn’t track the exact number — he notes that there is a growing need for two key reasons: to provide continuity of care when a patient returns home after a hospital stay and because of the increase in diabetes and obesity. http://www.drugtopics.com http://WWW.DRUGTOPICS.COM
Table of Contents Feed for the Digital Edition of Drug Topics - February 2009 Drug Topics - February 2009 Contents Health-System Edition Group Attempts to Resurrect Pain Care Act HSE Business Management HSE Clinical Letters Up Front Up Front in Depth Community Practice Niche Pharmacies Serve Special Populations Special Report Oral Oncology Drugs New Drugs Update 2008 Approvals OTC New Products Viewpoint Drug Topics - February 2009 Drug Topics - February 2009 - Drug Topics - February 2009 (Page Cover1) Drug Topics - February 2009 - Drug Topics - February 2009 (Page Cover2) Drug Topics - February 2009 - Drug Topics - February 2009 (Page 1) Drug Topics - February 2009 - Drug Topics - February 2009 (Page 2) Drug Topics - February 2009 - Contents (Page 3) Drug Topics - February 2009 - Contents (Page 4) Drug Topics - February 2009 - Contents (Page 5) Drug Topics - February 2009 - Contents (Page 6) Drug Topics - February 2009 - Contents (Page 7) Drug Topics - February 2009 - Contents (Page 8) Drug Topics - February 2009 - Group Attempts to Resurrect Pain Care Act (Page H1) Drug Topics - February 2009 - HSE Business Management (Page H2) Drug Topics - February 2009 - HSE Business Management (Page H3) Drug Topics - February 2009 - HSE Business Management (Page H4) Drug Topics - February 2009 - HSE Business Management (Page H5) Drug Topics - February 2009 - HSE Clinical (Page H6) Drug Topics - February 2009 - HSE Clinical (Page H7) Drug Topics - February 2009 - HSE Clinical (Page H8) Drug Topics - February 2009 - HSE Clinical (Page 9) Drug Topics - February 2009 - HSE Clinical (Page 10) Drug Topics - February 2009 - Letters (Page 11) Drug Topics - February 2009 - Up Front (Page 12) Drug Topics - February 2009 - Up Front (Page 13) Drug Topics - February 2009 - Up Front in Depth (Page 14) Drug Topics - February 2009 - Up Front in Depth (Page 15) Drug Topics - February 2009 - Up Front in Depth (Page 16) Drug Topics - February 2009 - Up Front in Depth (Page 17) Drug Topics - February 2009 - Up Front in Depth (Page 18) Drug Topics - February 2009 - Up Front in Depth (Page 19) Drug Topics - February 2009 - Up Front in Depth (Page 20) Drug Topics - February 2009 - Community Practice (Page 21) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 22) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 23) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 24) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 25) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 26) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 27) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 28) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 29) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 30) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 31) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 32) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 33) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 34) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 35) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 36) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 37) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 38) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 39) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 40) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 41) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 42) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 43) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 44) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 45) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 46) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 47) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 48) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 49) Drug Topics - February 2009 - OTC (Page 50) Drug Topics - February 2009 - OTC (Page 51) Drug Topics - February 2009 - OTC (Page 52) Drug Topics - February 2009 - New Products (Page 53) Drug Topics - February 2009 - New Products (Page 54) Drug Topics - February 2009 - New Products (Page 55) Drug Topics - February 2009 - New Products (Page 56) Drug Topics - February 2009 - New Products (Page 57) Drug Topics - February 2009 - New Products (Page 58) Drug Topics - February 2009 - New Products (Page 59) Drug Topics - February 2009 - Viewpoint (Page 60) Drug Topics - February 2009 - Viewpoint (Page Cover3) Drug Topics - February 2009 - Viewpoint (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.